Which antihypertensive drug class is preferred in patients with hypertension and diabetes mellitus?

Study for the PANCE Precision Exam. Improve with flashcards and multiple choice questions, each question has hints and explanations. Get ready for your exam!

Multiple Choice

Which antihypertensive drug class is preferred in patients with hypertension and diabetes mellitus?

Explanation:
When diabetes is present, protecting the kidneys becomes a top priority in managing hypertension. Drugs that block the renin-angiotensin system—ACE inhibitors or ARBs—are favored because they reduce intraglomerular pressure and lessen protein leakage into the urine, slowing the progression of diabetic nephropathy. They also provide meaningful cardiovascular protection, which is especially important since diabetes increases cardiovascular risk. Other options don’t offer the same kidney and metabolic advantages. Thiazide diuretics can worsen glucose tolerance and lipid levels; beta blockers may blunt warning signs of hypoglycemia and have less favorable metabolic effects; alpha-adrenergic blockers don’t provide the same renal benefits. For these reasons, ACE inhibitors or ARBs are the preferred first-line choice in patients with hypertension and diabetes.

When diabetes is present, protecting the kidneys becomes a top priority in managing hypertension. Drugs that block the renin-angiotensin system—ACE inhibitors or ARBs—are favored because they reduce intraglomerular pressure and lessen protein leakage into the urine, slowing the progression of diabetic nephropathy. They also provide meaningful cardiovascular protection, which is especially important since diabetes increases cardiovascular risk.

Other options don’t offer the same kidney and metabolic advantages. Thiazide diuretics can worsen glucose tolerance and lipid levels; beta blockers may blunt warning signs of hypoglycemia and have less favorable metabolic effects; alpha-adrenergic blockers don’t provide the same renal benefits. For these reasons, ACE inhibitors or ARBs are the preferred first-line choice in patients with hypertension and diabetes.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy